Kết quả áp dụng phẫu thuật Ecmo trong hồi sức phẫu thuật tim bẩm sinh phức tạp tại Bệnh viện Trung Ương Huế

Bui Duc Phu , Doan Duc Hoang , Tran Thi Tinh My , Nguyen Thi Ngoc Tam , Nguyen Thi Doan Trang

Main Article Content

Abstract

In Hue Cardiovascular Center, thousands of open heart operation cases have been successfully done annually for patients with valvular heart disease,  coronary artery disease, congenital heart disease. A few of them must need a temporary circulatory assistance in order to await the cardiac function recovery after complex anatomical surgical repairs. Successful implementation of ECMO technique in Hue Central Hospital gives a chance of survival for patients with more complex and severe cardiovascular pathology which could not be saved with previous conventional medical and pharmacologic management. In reverse, ECMO supports the development of cardiac surgery because it widens the indications of cardiovascular pathology which was assessed to be unable to treat due to lack of supportive and intensive care for patients who face with major risk surgery. 

Article Details

References

1. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB: Extracorporeal Life Support: The University of Michigan Experience. JAMA 283(7):904- 8, 2010.
2. Bùi Đức Phú và Cộng sự, “Nghiên cứu triển khai ghép tim trên người lấy từ người cho chết não”, Báo cáo kết quả đề tài nghiên cứu khoa hoc cấp nhà nước 03 - 2011.
3. Chistian F., Awad SS, Kolla S, Annich G, Reickert CA, Schreiner RJ, Hirschl RB, Bartlett, RH: Contre pulsion par ballon intra-aortique. J Crit Care 13:26-36, 2009.
4. Christian W. Hamm, Stephan Agewanll, Jeroen Bax, Eric Boersma, Kurt Huber. ESC guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elecation of the European Society of Cardiology (ESC). The European Society of Cardiology 2011
5. Cohn JN et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 2009; 314:1547
6. D. K. C. Cooper, and al., The Present Status of Xenotransplantation and Its Potential Role in the Treatment of End-Stage Cardiac and Pulmonary Diseases, © 2011 The Journal of Heart and Lung Transplantation.
7. Lynne Warner Stevenson, MD, FACC, Robert Kormos, MD,. Mechanical Cardiac Support 2000: Current Applications and Future Trial Design. Conference report 2011.
8. Shanley CJ, Hirschl RB, Schumacher RE, Overbeck MC, Delosh TN, Chapman RA, Coran AG, Barteltt RH: Extracorporeal Life Support for Respiratory Failure: 20 Year Experience. Ann Surg 220:269-282, 2010.
9. Swaniker F, Srinivas K, Moler F, Custer J, Grams R, Bartlett R, Hirschl RB: Extracorporeal life support (ECLS) outcome for 128 pediatric patients with respiratory failure. J Ped Surg 35:197-202, 2011.
10. Wenneth Dickstein, Panos E. Vardas, Jean-Claude Daubert, John McMuray. An update of the 2008 of ESC guidelines on device therapy in heart failure. The European Society of Cardiology 2011.